Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.900
-0.090 (-3.01%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Cellectis Market Cap
Cellectis has a market cap or net worth of $210.41 million as of July 14, 2026. Its market cap has increased by 95.55% in one year.
Market Cap
210.41M
Enterprise Value
108.48M
1-Year Change
95.55%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $210.41M, a decrease of -84.34%. That is a compound annual growth rate of -15.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 210.41M | -39.90% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 226.06M |
| Precision BioSciences | 226.03M |
| Camp4 Therapeutics | 224.84M |
| Codexis | 220.88M |
| Minerva Neurosciences | 219.90M |
| NovaBridge Biosciences | 219.73M |
| Whitehawk Therapeutics | 213.52M |
| Atrium Therapeutics | 213.14M |